Detalhe da pesquisa
1.
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643491
2.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832030
3.
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.
Circulation
; 148(21): 1680-1690, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746692
4.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050405
5.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Haematologica
; 108(1): 22-33, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545919
6.
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma - All StAGEs: A consensus-based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research Institute.
Br J Haematol
; 197(6): 679-690, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362554
7.
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Br J Haematol
; 197(5): 558-572, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191541
8.
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Br J Haematol
; 196(4): 892-901, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761389
9.
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Br J Haematol
; 198(3): 492-502, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485402
10.
Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1.
Value Health
; 25(6): 1010-1017, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667774
11.
Checkpoint Inhibitors and the Changing Face of the Relapsed/Refractory Classical Hodgkin Lymphoma Pathway.
Curr Oncol Rep
; 24(11): 1477-1488, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696020
12.
Epigenetic targeting in lymphoma.
Br J Haematol
; 192(1): 50-61, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609383
13.
Limited-stage diffuse large B-cell lymphoma: current management and challenges.
Br J Haematol
; 194(3): 508-517, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618434
14.
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY).
Br J Haematol
; 193(1): 63-71, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926420
15.
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
N Engl J Med
; 379(18): 1711-1721, 2018 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380386
16.
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
BMC Cancer
; 21(1): 851, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301221
17.
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lancet Oncol
; 21(10): 1309-1316, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853557
18.
What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options.
Br J Haematol
; 188(6): 831-837, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880329
19.
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
Br J Haematol
; 189(1): 128-132, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31710702
20.
Tackling PD1i resistance in Hodgkin lymphoma.
Blood
; 142(16): 1333-1334, 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856096